scholarly journals Cannabinoid Type 1 Receptor Antagonists Modulate Transport Activity of Multidrug Resistance-Associated Proteins MRP1, MRP2, MRP3, and MRP4

2011 ◽  
Vol 39 (7) ◽  
pp. 1294-1302 ◽  
Author(s):  
Hanneke G. M. Wittgen ◽  
Jeroen J. M. W. van den Heuvel ◽  
Petra H. H. van den Broek ◽  
Heike Dinter-Heidorn ◽  
Jan B. Koenderink ◽  
...  
2012 ◽  
Vol 9 (5) ◽  
pp. 1351-1360 ◽  
Author(s):  
Hanneke G. M. Wittgen ◽  
Rick Greupink ◽  
Jeroen J. M. W. van den Heuvel ◽  
Petra H. H. van den Broek ◽  
Heike Dinter-Heidorn ◽  
...  

2009 ◽  
Vol 52 (14) ◽  
pp. 4329-4337 ◽  
Author(s):  
György Szabó ◽  
Balázs Varga ◽  
Dóra Páyer-Lengyel ◽  
Attila Szemző ◽  
Péter Erdélyi ◽  
...  

2009 ◽  
Vol 19 (13) ◽  
pp. 3471-3475 ◽  
Author(s):  
György Szabó ◽  
Róbert Kiss ◽  
Dóra Páyer-Lengyel ◽  
Krisztina Vukics ◽  
Judit Szikra ◽  
...  

2021 ◽  
Vol 22 (7) ◽  
pp. 3595
Author(s):  
Md Afjalus Afjalus Siraj ◽  
Md. Sajjadur Rahman ◽  
Ghee T. Tan ◽  
Veronique Seidel

A molecular docking approach was employed to evaluate the binding affinity of six triterpenes, namely epifriedelanol, friedelin, α-amyrin, α-amyrin acetate, β-amyrin acetate, and bauerenyl acetate, towards the cannabinoid type 1 receptor (CB1). Molecular docking studies showed that friedelin, α-amyrin, and epifriedelanol had the strongest binding affinity towards CB1. Molecular dynamics simulation studies revealed that friedelin and α-amyrin engaged in stable non-bonding interactions by binding to a pocket close to the active site on the surface of the CB1 target protein. The studied triterpenes showed a good capacity to penetrate the blood–brain barrier. These results help to provide some evidence to justify, at least in part, the previously reported antinociceptive and sedative properties of Vernonia patula.


2006 ◽  
Vol 71 (10) ◽  
pp. 1470-1478 ◽  
Author(s):  
J.M. Maher ◽  
X. Cheng ◽  
Y. Tanaka ◽  
G.L. Scheffer ◽  
C.D. Klaassen

Sign in / Sign up

Export Citation Format

Share Document